Biovica
Biovica is a diagnostics and pharma services company focused on blood-based tumor proliferation testing for cancer monitoring and oncology drug development. Its DiviTum® TKa assay is FDA 510(k) cleared in the US and supported by Biovica’s CLIA-certified laboratory in San Diego, California.
Biovica helps oncology drug developers achieve their clinical development objectives by providing earlier biological insight into treatment effect and tumor proliferation dynamics. Its DiviTum TKa assay measures thymidine kinase activity as a translational blood-based biomarker, offering a pharmacodynamic readout of tumor proliferation and biological drug activity.
Biovica partners with pharma, and biotech across preclinical and clinical development to support dose optimization, patient stratification, treatment-response monitoring and exploratory biomarker strategies.
